Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260


The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients.

Parsons RF, Zahid A, Bumb S, Decker H, Sullivan HC, Eun-Hyung Lee F, Badell IR, Ford ML, Larsen CP, Pearson TC, Jackson AM, Chen DF, Levine M, Kamoun M, Bray RA, Gebel HM.

Am J Transplant. 2020 Feb;20(2):573-581. doi: 10.1111/ajt.15585. Epub 2019 Oct 8.


Kinetics of antibody response to influenza vaccination in renal transplant recipients.

Gangappa S, Wrammert J, Wang D, Li ZN, Liepkalns JS, Cao W, Chen J, Levine MZ, Stevens J, Sambhara S, Begley B, Mehta A, Pearson TC, Ahmed R, Larsen CP.

Transpl Immunol. 2019 Apr;53:51-60. doi: 10.1016/j.trim.2019.01.001. Epub 2019 Jan 18.


Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population: A Randomized, Controlled Trial.

Basu M, Petgrave-Nelson L, Smith KD, Perryman JP, Clark K, Pastan SO, Pearson TC, Larsen CP, Paul S, Patzer RE.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):620-627. doi: 10.2215/CJN.08600817. Epub 2018 Mar 26.


Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.

Adams AB, Goldstein J, Garrett C, Zhang R, Patzer RE, Newell KA, Turgeon NA, Chami AS, Guasch A, Kirk AD, Pastan SO, Pearson TC, Larsen CP.

Am J Transplant. 2017 Nov;17(11):2922-2936. doi: 10.1111/ajt.14353. Epub 2017 Jul 3.


Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.

Kim SC, Wakwe W, Higginbotham LB, Mathews DV, Breeden CP, Stephenson AC, Jenkins J, Strobert E, Price K, Price L, Kuhn R, Wang H, Yamniuk A, Suchard S, Farris AB 3rd, Pearson TC, Larsen CP, Ford ML, Suri A, Nadler S, Adams AB.

Am J Transplant. 2017 May;17(5):1182-1192. doi: 10.1111/ajt.14197. Epub 2017 Feb 25.


Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.

Weir MR, Pearson TC, Patel A, Peddi VR, Kalil R, Scandling J, Chan L, Baliga P, Melton L, Mulgaonkar S, Waid T, Schaefer H, Youssef N, Anandagoda L, McCollum D, Lawson S, Gordon R.

Transplantation. 2017 Jan;101(1):157-165. doi: 10.1097/TP.0000000000001098.


Utility of Prostate Cancer Screening in Kidney Transplant Candidates.

Vitiello GA, Sayed BA, Wardenburg M, Perez SD, Keith CG, Canter DJ, Ogan K, Pearson TC, Turgeon N.

J Am Soc Nephrol. 2016 Jul;27(7):2157-63. doi: 10.1681/ASN.2014121182. Epub 2015 Dec 23.


Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.

Kirk AD, Guasch A, Xu H, Cheeseman J, Mead SI, Ghali A, Mehta AK, Wu D, Gebel H, Bray R, Horan J, Kean LS, Larsen CP, Pearson TC.

Am J Transplant. 2014 May;14(5):1142-51. doi: 10.1111/ajt.12712. Epub 2014 Mar 31.


Targeting co-stimulatory pathways: transplantation and autoimmunity.

Ford ML, Adams AB, Pearson TC.

Nat Rev Nephrol. 2014 Jan;10(1):14-24. doi: 10.1038/nrneph.2013.183. Epub 2013 Oct 8. Review.


Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.

Harbell J, Fung J, Nissen N, Olthoff K, Florman SS, Hanto DW, Light J, Bartlett ST, Tzakis AG, Pearson TC, Barin B, Roland ME, Stock PG; HIV-TR Investigators.

Surgery. 2012 Sep;152(3):376-81. doi: 10.1016/j.surg.2012.06.012.


Racial disparities in kidney graft survival: does donor quality explain the difference?

Patzer RE, Pearson TC.

Am J Transplant. 2012 Jul;12(7):1670-1. doi: 10.1111/j.1600-6143.2012.04093.x. No abstract available.


CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8.

Badell IR, Russell MC, Cardona K, Shaffer VO, Turner AP, Avila JG, Cano JA, Leopardi FV, Song M, Strobert EA, Ford ML, Pearson TC, Kirk AD, Larsen CP.

Am J Transplant. 2012 Jul;12(7):1918-23. doi: 10.1111/j.1600-6143.2012.04029.x. Epub 2012 Mar 28.


The impact of renal function on outcomes of bariatric surgery.

Turgeon NA, Perez S, Mondestin M, Davis SS, Lin E, Tata S, Kirk AD, Larsen CP, Pearson TC, Sweeney JF.

J Am Soc Nephrol. 2012 May;23(5):885-94. doi: 10.1681/ASN.2011050476. Epub 2012 Mar 1.


Miles to go….

Kirk AD, Knechtle SJ, Larsen CP, Newell KA, Pearson TC.

Am J Transplant. 2011 Jun;11(6):1119-20. doi: 10.1111/j.1600-6143.2011.03542.x. No abstract available.


Images in emergency medicine. Woman with right eye pain and swelling. Partial globe rupture.

Wu TS, Dommer P, Pearson TC.

Ann Emerg Med. 2011 Jun;57(6):703, 708. doi: 10.1016/j.annemergmed.2010.08.033. No abstract available.


Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.

Dar W, Agarwal A, Watkins C, Gebel HM, Bray RA, Kokko KE, Pearson TC, Knechtle SJ.

Am J Transplant. 2011 Apr;11(4):841-7. doi: 10.1111/j.1600-6143.2011.03467.x.


Bedside ultrasound diagnosis of a traumatic bladder rupture.

Wu TS, Pearson TC, Meiners S, Daugharthy J.

J Emerg Med. 2011 Nov;41(5):520-3. doi: 10.1016/j.jemermed.2011.01.022. Epub 2011 Mar 25.


Pillars article: long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996. 381: 434-438. 1996.

Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC.

J Immunol. 2011 Mar 1;186(5):2693-7. No abstract available.


Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.

Weir MR, Mulgaonkar S, Chan L, Shidban H, Waid TH, Preston D, Kalil RN, Pearson TC.

Kidney Int. 2011 Apr;79(8):897-907. doi: 10.1038/ki.2010.492. Epub 2010 Dec 29.


Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.

Turgeon NA, Avila JG, Cano JA, Hutchinson JJ, Badell IR, Page AJ, Adams AB, Sears MH, Bowen PH, Kirk AD, Pearson TC, Larsen CP.

Am J Transplant. 2010 Sep;10(9):2082-91. doi: 10.1111/j.1600-6143.2010.03212.x.


Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.

Martin DR, Krishnamoorthy SK, Kalb B, Salman KN, Sharma P, Carew JD, Martin PA, Chapman AB, Ray GL, Larsen CP, Pearson TC.

J Magn Reson Imaging. 2010 Feb;31(2):440-6. doi: 10.1002/jmri.22024.


Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation.

Gilson CR, Milas Z, Gangappa S, Hollenbaugh D, Pearson TC, Ford ML, Larsen CP.

J Immunol. 2009 Aug 1;183(3):1625-35. doi: 10.4049/jimmunol.0900339. Epub 2009 Jul 10.


The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study.

Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P.

Transplantation. 2009 May 15;87(9):1360-6. doi: 10.1097/TP.0b013e3181a23cb2.


Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses.

Anderson A, Martens CL, Hendrix R, Stempora LL, Miller WP, Hamby K, Russell M, Strobert E, Blazar BR, Pearson TC, Larsen CP, Kean LS.

Am J Transplant. 2008 Nov;8(11):2252-64. doi: 10.1111/j.1600-6143.2008.02376.x. Epub 2008 Sep 17.


CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion.

Rigby MR, Trexler AM, Pearson TC, Larsen CP.

Diabetes. 2008 Oct;57(10):2672-83. doi: 10.2337/db07-1712. Epub 2008 May 20.


A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection.

Ford ML, Wagener ME, Hanna SS, Pearson TC, Kirk AD, Larsen CP.

J Immunol. 2008 Jun 1;180(11):7203-11.


Immune responsiveness and protective immunity after transplantation.

Gangappa S, Kokko KE, Carlson LM, Gourley T, Newell KA, Pearson TC, Ahmed R, Larsen CP.

Transpl Int. 2008 Apr;21(4):293-303. doi: 10.1111/j.1432-2277.2007.00631.x. Epub 2008 Jan 21. Review.


Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways.

Cardona K, Milas Z, Strobert E, Cano J, Jiang W, Safley SA, Gangappa S, Hering BJ, Weber CJ, Pearson TC, Larsen CP.

Am J Transplant. 2007 Oct;7(10):2260-8.


Fully MHC-disparate mixed hemopoietic chimeras show specific defects in the control of chronic viral infections.

Koehn BH, Williams MA, Borom K, Gangappa S, Pearson TC, Ahmed R, Larsen CP.

J Immunol. 2007 Aug 15;179(4):2616-26.


NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.

Hamby K, Trexler A, Pearson TC, Larsen CP, Rigby MR, Kean LS.

Am J Transplant. 2007 Aug;7(8):1884-96.


Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models.

Ford ML, Wagener ME, Gangappa S, Pearson TC, Larsen CP.

Am J Transplant. 2007 Jun;7(6):1471-81.


Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation.

Ford ML, Koehn BH, Wagener ME, Jiang W, Gangappa S, Pearson TC, Larsen CP.

J Exp Med. 2007 Feb 19;204(2):299-309. Epub 2007 Jan 29.


Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression.

Kean LS, Adams AB, Strobert E, Hendrix R, Gangappa S, Jones TR, Shirasugi N, Rigby MR, Hamby K, Jiang J, Bello H, Anderson D, Cardona K, Durham MM, Pearson TC, Larsen CP.

Am J Transplant. 2007 Feb;7(2):320-35.


Alloimmunity: no toll exemption.

Gangappa S, Larsen CP, Pearson TC.

Am J Transplant. 2007 Jan;7(1):3-4. No abstract available. Erratum in: Am J Transplant. 2007 Jun;7(6):1681.


Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

Vezys V, Masopust D, Kemball CC, Barber DL, O'Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE.

J Exp Med. 2006 Oct 2;203(10):2263-9. Epub 2006 Sep 11.


Imaging and automated detection of Sitophilus oryzae (Coleoptera: Curculionidae) pupae in hard red winter wheat.

Toews MD, Pearson TC, Campbell JF.

J Econ Entomol. 2006 Apr;99(2):583-92.


Organ donation and utilization, 1995-2004: entering the collaborative era.

Marks WH, Wagner D, Pearson TC, Orlowski JP, Nelson PW, McGowan JJ, Guidinger MK, Burdick J.

Am J Transplant. 2006;6(5 Pt 2):1101-10.


A mouse model for polyomavirus-associated nephropathy of kidney transplants.

Han Lee ED, Kemball CC, Wang J, Dong Y, Stapler DC Jr, Hamby KM, Gangappa S, Newell KA, Pearson TC, Lukacher AE, Larsen CP.

Am J Transplant. 2006 May;6(5 Pt 1):913-22.


Transplant tolerance in non-human primates: progress, current challenges and unmet needs.

Kean LS, Gangappa S, Pearson TC, Larsen CP.

Am J Transplant. 2006 May;6(5 Pt 1):884-93. Review.


Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways.

Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, Weber CJ, Pearson TC, Rajotte RV, Larsen CP.

Nat Med. 2006 Mar;12(3):304-6. Epub 2006 Feb 26.


Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.

Emmanouilidis N, Guo Z, Dong Y, Newton-West M, Adams AB, Lee ED, Wang J, Pearson TC, Larsen CP, Newell KA.

Transplantation. 2006 Feb 15;81(3):455-62.


NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation.

Kean LS, Hamby K, Koehn B, Lee E, Coley S, Stempora L, Adams AB, Heiss E, Pearson TC, Larsen CP.

Am J Transplant. 2006 Feb;6(2):292-304.


Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.

Kemball CC, Lee ED, Szomolanyi-Tsuda E, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2006 Feb 1;176(3):1814-24.


High-Speed Optical Sorting of Soft Wheat for Reduction of Deoxynivalenol.

Delwiche SR, Pearson TC, Brabec DL.

Plant Dis. 2005 Nov;89(11):1214-1219. doi: 10.1094/PD-89-1214.


Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, Wilkins B; General Haematology Task Force of the British Committee for Standards in Haematology.

Br J Haematol. 2005 Jul;130(2):174-95. No abstract available.


Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.

Kemball CC, Lee ED, Vezys V, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2005 Jun 15;174(12):7950-60.


Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobert E, Anderson D, Cowan S, Price K, Naemura J, Emswiler J, Greene J, Turk LA, Bajorath J, Townsend R, Hagerty D, Linsley PS, Peach RJ.

Am J Transplant. 2005 Mar;5(3):443-53.


Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.

Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, Hagerty D, Townsend R, Hollenbaugh D, Pearson TC, Larsen CP.

J Immunol. 2005 Jan 1;174(1):542-50.


Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.

Shirasugi N, Emmanouilidis N, Pearson TC, Larsen CP.

Transplant Proc. 2004 Oct;36(8):2423-4.


Intravital microscopy identifies selectins that regulate T cell traffic into allografts.

Jones TR, Shirasugi N, Adams AB, Pearson TC, Larsen CP.

J Clin Invest. 2003 Dec;112(11):1714-23.

Supplemental Content

Loading ...
Support Center